The role of next-generation sequencing in the diagnosis of lysosomal storage disorders

Komlósi, Katalin and Sólyom, Alexander and Beck, Michael (2016) The role of next-generation sequencing in the diagnosis of lysosomal storage disorders. Journal of Inborn Errors of Metabolism and Screening. ISSN 2326-4098 (In Press)

Preview

Text The role of NGS in LSDs_JIEMS.pdf - Accepted Version Download (137kB) | Preview

Abstract

Next-generation sequencing (NGS) panels are used widely in clinical diagnostics to identify genetic causes of various monogenic disease groups including neurometabolic disorders and, more recently, lysosomal storage disorders. Many new challenges have been introduced through these new technologies, both at the laboratory level and at the bioinformatics level, with consequences including new requirements for interpretation of results, and for genetic counseling. We review some recent examples of the application of NGS technologies, with purely diagnostic and with both diagnostic and research aims, for establishing a rapid genetic diagnosis in lysosomal storage disorders. Given that NGS can be applied in a way that takes into account the many issues raised by international consensus guidelines, it can have a significant role even early in the course of the diagnostic process, in combination with biochemical and clinical data. Besides decreasing the delay in diagnosis for many patients, a precise molecular diagnosis is extremely important as new therapies are becoming available within the LSD disease spectrum for patients who share specific types of mutations. A genetic diagnosis is also the prerequisite for genetic counseling, family planning and the individual choice of reproductive options in affected families.

Actions (login required)

Edit Item